MD-50 Drug Patent Profile
Which patents cover Md-50, and what generic alternatives are available?
Md-50 is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in MD-50 is diatrizoate sodium. There is one drug master file entry for this compound. Additional details are available on the diatrizoate sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MD-50?
- What are the global sales for MD-50?
- What is Average Wholesale Price for MD-50?
Summary for MD-50
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 4,519 |
| DailyMed Link: | MD-50 at DailyMed |
US Patents and Regulatory Information for MD-50
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | MD-50 | diatrizoate sodium | INJECTABLE;INJECTION | 087075-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
